Both medical and leisure cannabis sales in the U.S. increased 67 percent in 2020 compared to 2019, according to a Leafly analysis of state tax and earnings information. Overall cannabis sales have actually reached $17.9 billion this year, $7.2 billion more than the previous year’s sales.
The “primary motorist” of the boost, Leafly states, was a boost in the typical purchase size of developed consumers, who upped their month-to-month cannabis purchases in between 25% and 40% usually.
9 states– Arkansas, Connecticut, Florida, Illinois, Maine, New Jersey, North Dakota, Ohio, and Pennsylvania– doubled their cannabis sales from 2019, the report states. Maine, significantly, lastly introduced adult-use sales after almost 4 years of hold-ups and medical cannabis sales consequently went beyond potato, hay, wild blueberry, and milk sales to end up being the state’s most profitable crop. Florida’s medical cannabis sales topped $1.2 billion this year, making it the fourth-largest cannabis market in the U.S. this year, routing just the adult-use states of California, Colorado, and Washington, according to the report.
Leafly approximated the last weeks of cannabis sales by “presuming approximately the previous 3 months of earnings figures,” however prepares to release a complete account of the year’s sales figures in their yearly Cannabis Jobs Report which the business prepares to launch in February.